Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
0 structures for Q2Y2M4
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|
No variants for Q2Y2M4
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q2Y2M4 | |||||
No associated diseases with Q2Y2M4
No regional properties for Q2Y2M4
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q2Y2M4 | |||
Functions
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| host cell cytoplasm | The cytoplasm of a host cell. |
| host cell nucleus | A membrane-bounded organelle as it is found in the host cell in which chromosomes are housed and replicated. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
| host cell plasma membrane | The plasma membrane surrounding a host cell. |
| membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| viral envelope | The lipid bilayer of a virion that surrounds the protein capsid. May also contain glycoproteins. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| structural constituent of virion | The action of a molecule that contributes to the structural integrity of a virion. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| virion assembly | A late phase of the viral life cycle during which all the components necessary for the formation of a mature virion collect at a particular site in the cell and the basic structure of the virus particle is formed. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MESYLVDTYQ | GVPYTAAVQT | DLVEKDQLPA | RLTVWFPLFQ | TNTPPTVLLE | QLKTLTITTL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| YTASQNGPIL | KVNASAQGAA | MSALPKSFDV | SASVALDDYS | KLEFDKLTVC | ELKAVYLTTM |
| 130 | 140 | 150 | 160 | 170 | 180 |
| KPYGMVSKFV | NSAKAVGKKT | HDLIALCDFL | DLEKGVPVTI | PAYIKSVSIK | ESESATVEAA |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IGGEADQAIT | QARIAPYAGL | IMIMTMNNPK | GIFKKLGAGV | QVIVELGAYV | QAESISRICR |
| 250 | |||||
| NWSHQGTRYV | LKSR |